cpg-dna enhancement the immune elicited as adjuvant of foot- and- mouth disease vaccine

in the present study the effect of the locally produced genetic adjuvant of ginea pig specific cpg-motif-containing oligodeoxynucleotide (cpg-odn) in an inactivated fmd virus vaccine was evaluated. boosting the ginea pigs with fmd vaccine along with cpg-odn adjuvant produced relatively higher ratio (5-fold) of fmdv-specific igg2a / igg1 than those vaccinated in the absence of cpg-odn. the neutralizing antibody (na) titer induced by fmd vaccine along with cpg-odn adjuvant was significantly higher (8-fold) than na titer induced by the classical fmd vaccine in alum adjuvant. the titer of na and virus clearance from serum was consistently and significantly higher in animals primed with fmd vaccine and boosted by cpg-odn than the classical fmd vaccine. the results of this study showed the potential of cpg-odn as a genetic adjuvant to fmd vaccine in the development of th1 responses.